Press Release

Medidata Wins International Innovation Awards 2020

The company’s newly released solution received the prestigious International Innovation Award (IIA) 2020 for “myMedidata – The Industry’s First Patient Portal Platform”

 

Singapore -- (December 16, 2020) -- Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutionsthat support the entire clinical trial process, received the prestigious International Innovation Award (IIA) 2020 for myMedidata – The Industry’s First Patient Portal Platform”. myMedidata is a single-destination patient portal enabling virtual participation in clinical trials for new medicines,vaccines, and research. The Award commended Medidata for launching the industry’s first patient portal providing a holistic solution from the recruitment of patients to virtual participation with remote patient data capture and live video visits along with the return of patient data to the participant.

Organized by Enterprise Asia, the annual IIA recognition program recognizes outstanding innovations in the categories of Product, Service and Solution, and Organization and Culture with the goal encouraging organizations to continue investing in innovation. Medidata was selected as the winner under the Service & Solution category out of the 120 submissions from over 13 countries. 

“We are honoured to be recognized for our efforts in advancing innovation and redefining the clinical trial industry,” said Edwin Ng, Senior Vice President, General Manager Sales, APeJ, Medidata. “Patient-centered technologies will be the new foundation of life sciences. We must provide patients with the ability to virtually access and actively engage in their own health care needs. This is particularly relevant during the current COVID-19 pandemic when in-person visits might be restricted, yet patients still require a continuum of care from existing clinical trials, regardless of their location.”

myMedidata provides a unified experience for patients and sites, expanding access to all of Medidata’s Patient Cloud tools and built directly on the industry-leading, regulatory-compliant Medidata Rave Clinical Cloud. It was developed using insights from Medidata’s Patient Insights team and made to be accessible from any device with an internet connection.

Launched in April 2020, the first release included a research-based COVID-19 symptom tracker, designed to support research organizations to follow patients’ COVID-19 symptoms for their ongoing and future trials, and advance scientific understanding of the virus. In October 2020, the latest release includes remote eConsent, eCOA, and myMedidata LIVE, a web-based, live video conferencing capability. With myMedidata LIVE, patients can virtually connect with their clinical trial study staff, providing researchers and patients a way to remain engaged in remote site visits within the platform of site and patient-facing technologies.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

###

About Medidata

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,600+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data. Medidata, a

Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata, The Operating System for Life SciencesTM.

Medidata and Medidata Rave, and Patient Cloud are registered trademarks of Medidata Solutions, Inc., a wholly owned subsidiary of Dassault Systèmes.

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual experience twins of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. Dassault Systèmes brings value to more than 270,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com.

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, EXALEAD, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French “société européenne” (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries.

Contact

Koh Shu Mei

shumei.koh@omnicomprgroup.com